Oesophageal carcinoma+1
RecruitingStudy of drug combination therapy for patients with lymph node-positive esophageal and esophagogastric junction cancer using carboplatin, paclitaxel, fluorouracil, folinic acid, docetaxel and oxaliplatin
Study of drug combination therapy for patients with lymph node-positive esophageal and esophagogastric junction cancer using carboplatin, paclitaxel, fluorouracil, folinic acid, docetaxel and oxaliplatin
- Disease:Oesophageal carcinomaOesophageal adenocarcinoma
- Substances:CarboplatinDocetaxel+4
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Carboplatin











